Read the new Microsoft Cyberattack Series report to learn more about on how deception and trusted tools can enable ...
Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results